LEADER 01197nam0-2200361---450-
001 990009456850403321
005 20111019104544.0
035   $a000945685
035   $aFED01000945685
035   $a(Aleph)000945685FED01
035   $a000945685
100   $a20111019d1948----km-y0itay50------ba
101 1 $aita$ceng
102   $aIT
105   $ay-------001yy
200 1 $a<<I >>gruppi sanguigni Rh e la loro importanza clinica$fP. L. Mollison, A. E. Mourant, R. R. Race$gtraduzione di L. L. Cavalli e R. Ceppellini
210   $aMilano$cIstituto sieroterapico milanese S. Belfanti$d1948
215   $aXVI, 149 p.$d22 cm
225 1 $aMedical research council$v19
610 0 $aGruppi sanguigni
676   $a612.118$v19$zita
700  1$aMollison,$bPatrick London$0513602
701  1$aMourant,$bArthur Ernest$0513603
701  1$aRace,$bRobert Russell$0513604
702  1$aCavalli-Sforza,$bLuigi Luca$f<1922- >
702  1$aCeppellini,$bRuggero
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990009456850403321
952   $a43 F 10$bs.i.$fDMVAP
959   $aDMVAP
996   $aGruppi sanguigni Rh e la loro importanza clinica$9761478
997   $aUNINA